How to more efficiently study complex treatment interactions
A new approach for testing multiple treatment combinations at once could help scientists develop drugs for cancer or genetic disorders.
Learn about artificial intelligence, GPT usage, prompt engineering and other technology news and updates from Land of GPT. The site aggregates articles from official RSS feeds under their original authorship. Each article has a do-follow link to the original source.
A new approach for testing multiple treatment combinations at once could help scientists develop drugs for cancer or genetic disorders.
Trained with a joint understanding of protein and cell behavior, the model could help with diagnosing disease and developing new drugs.
ReviveMed uses AI to gather large-scale data on metabolites — molecules like lipids, cholesterol, and sugar — to match patients with therapeutics.
Whitehead Institute and CSAIL researchers created a machine-learning model to predict and generate protein localization, with implications for understanding and remedying disease.
Using this model, researchers may be able to identify antibody drugs that can target a variety of infectious diseases.
The model could help clinicians assess breast cancer stage and ultimately help in reducing overtreatment.
Co-hosted by the McGovern Institute, MIT Open Learning, and others, the symposium stressed emerging technologies in advancing understanding of mental health and neurological conditions.